NDC 68084-862-95 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-862
- Requested NDC
- 68084-862-95
- Package NDCs from labels
- 68084-862-95, 68084-862-25, 68084-862-11, 68084-862-01
- Manufacturer
- American Health Packaging
- Effective date
- 2025-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - American Health Packaging | American Health Packaging | 2025-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-862-01 | Doxazosin | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 9 | |
| 68084-862-11 | Doxazosin | 1 in 1 BLISTER PACK | TABLET | 1 | 9 | |
| 68084-862-25 | Doxazosin | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 9 | |
| 68084-862-95 | Doxazosin | 1 in 1 BLISTER PACK | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-862-01 | EA - Each | 68084-862 | b1397f3f-b113-45bf-9bea-0cd4c0bcd693 | 1 | 2020-07-13 |
| 68084-862-11 | EA - Each | 68084-862 | 2bcd84c9-feb5-421b-901d-aaab8fbcce7a | 1 | 2014-11-05 |
| 68084-862-21 | EA - Each | 68084-862 | db144491-a035-4575-b589-85647f381654 | 1 | 2014-11-05 |
| 68084-862-25 | EA - Each | 68084-862 | f320eb12-5600-4012-8063-1cceef548ad8 | 1 | 2016-03-04 |
| 68084-862-95 | EA - Each | 68084-862 | 6b831af3-16a1-41a7-82bf-bbe311879b86 | 1 | 2016-03-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXAZOSIN MESYLATE | ACTIVE INGREDIENT | 86P6PQK0MU | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| DOXAZOSIN | ACTIVE MOIETY | NW1291F1W8 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DOXAZOSIN TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | b364c7a8-72b5-4776-a500-400c37a72c9b | 2022-02-03 | Warnings, Adverse reactions | 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Mylan Pharmaceuticals Inc. | 6b887aa5-5edf-48c5-a480-dea8c35afa9d | 2022-01-20 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | ROERIG | eefc47bc-c10f-49bb-8ef7-5999f798ab39 | 2022-01-20 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | f1dc70f6-4329-46da-8990-7bd6eec9d37d | 2021-12-07 | Warnings, Adverse reactions | ANDA075580 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Teva Pharmaceuticals USA, Inc. | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 2021-11-30 | Warnings, Adverse reactions | 197625 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 6b74b18f-b89a-4109-a29e-c4fa65a3c5ee | 2020-12-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d | 2018-03-06 | Warnings, Adverse reactions | ANDA075580 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.